THE EFFECT OF A DUAL RECEPTOR GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON AGONIST, COTADUTIDE, ON SERUM METABOLOME IN BIOPSY PROVEN NON-CIRRHOTIC NASH WITH FIBROSIS

被引：0
|
作者：
Daniels, Samuel J. [1 ]
Robertson, Darren [1 ]
Challis, Benjamin [2 ]
Sanyal, Arun J. [3 ]
Shankar, Sudha S. [4 ]
机构：
[1] Astrazeneca, Early Clin Dev Cardiovasc Renal & Metab, Biopharmaceut R&D, Cambridge, England
[2] Astrazeneca, Translat Sci & Expt Med, Res & Early Dev, Cardiovasc Renal & Metab,Biopharmaceut R&D, Cambridge, England
[3] Stravitz Sanyal Inst Liver Dis & Metab Hlth, VCU Sch Med, Dept Internal Med, Richmond, VA USA
[4] Astrazeneca, Early & Late Clin Dev, Cardiovasc Renal & Metab, Biopharmaceut R& D, Cambridge, England
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
101
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [41] Glucagon-like peptide-1 receptor action in the vasculature
    Almutairi, Malak
    Al Batran, Rami
    Ussher, John R.
    PEPTIDES, 2019, 111 : 26 - 32
  • [42] SIGNAL TRANSDUCTION OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR
    LU, M
    WHEELER, MB
    DILLON, J
    LENG, XH
    CHEN, C
    BOYD, AE
    DIABETES, 1993, 42 : A76 - A76
  • [43] Physiology and pharmacology of glucagon-like peptide-1 receptor
    Kurkin, D. V.
    Bakulin, D. A.
    Morkovin, E. I.
    Petrov, V. I.
    Strygin, A. V.
    Koryanova, K. N.
    Gorbunova, Yu. V.
    Kolosov, Yu. A.
    Ivanova, O. V.
    Pavlova, E. V.
    Dzhavahyan, M. A.
    Zaborovsky, A. V.
    Saparova, V. B.
    Makarenko, I. E.
    Drai, R. I.
    Chumachenko, A. N.
    PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2023, 11 (04): : 347 - 380
  • [44] Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists
    Khan, Sadiya S.
    Ndumele, Chiadi E.
    Kazi, Dhruv S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (02): : 113 - 114
  • [45] Understanding signaling at the glucagon-like peptide-1 receptor
    Sexton, Patrick M.
    Pabreja, Kavita
    Koole, Cassandra
    Savage, Emilia E.
    Furness, Sebastian G.
    Christopoulos, Arthur
    Wootten, Denise
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 89 - 89
  • [46] Pitfalls in Glucagon-Like Peptide-1 Receptor Imaging
    Antwi, K.
    Hepprich, M.
    Reubi, J. C.
    Christ, E.
    Wild, D.
    NEUROENDOCRINOLOGY, 2020, 110 : 248 - 248
  • [47] Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease
    Parker, Victoria E. R.
    Hoang, Thuong
    Schlichthaar, Heike
    Gibb, Fraser W.
    Wenzel, Barbara
    Posch, Maximillian G.
    Rose, Ludger
    Chang, Yi-Ting
    Petrone, Marcella
    Hansen, Lars
    Ambery, Philip
    Jermutus, Lutz
    Heerspink, Hiddo J. L.
    McCrimmon, Rory J.
    DIABETES OBESITY & METABOLISM, 2022, 24 (07): : 1360 - 1369
  • [48] Obesity and Glucagon-Like Peptide-1 Receptor Agonists
    Celletti, Francesca
    Branca, Francesco
    Farrar, Jeremy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (07): : 561 - 562
  • [49] Efficacy, tolerability and pharmacokinetics of survodutide, aglucagon/glucagon-like peptide-1 receptor dual agonist,in cirrhosis
    Lawitz, Eric J.
    Fraessdorf, Mandy
    Neff, Guy W.
    Schattenberg, Joern M.
    Noureddin, Mazen
    Alkhouri, Naim
    Schmid, Bernhard
    Andrews, Charles P.
    Takacs, Istvan
    Hussain, Samina Ajaz
    Fenske, Wiebke K.
    Gane, Edward J.
    Hosseini-Tabatabaei, Azadeh
    Sanyal, Arun J.
    Mazo, Daniel F.
    Younes, Ramy
    JOURNAL OF HEPATOLOGY, 2024, 81 (05)
  • [50] The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: A systematic review
    Nerup, Nikolaj
    Ambrus, Rikard
    Lindhe, Joanna
    Achiam, Michael P.
    Jeppesen, Palle B.
    Svendsen, Lars B.
    MICROCIRCULATION, 2019, 26 (03)
12345